Pfizer in Talks with Govt for Use of its Vac­cine

The Economic Times - - Sports -

Pfizer is in talks with the In­dian gov­ern­ment for in­clu­sion of its multi-dose vials of pneu­mo­coc­cal vac­cine, Prevnar 13, in the coun­try’s im­mu­ni­sa­tion pro­gramme, re­ports Vikas Dan­dekar from Mum­bai. The New York-head­quar­tered com­pany won Euro­pean ap­proval for the multi-dose vial pack of the in­fant and chil­dren’s vac­cine, which works against 13 strains of strep­to­coc­cus pneu­mo­nia bac­te­ria. The drug is Pfizer’s top-sell­ing brand lo­cally, ahead of Corex cough syrup.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.